METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metformin Hydrochloride; Saxagliptin Hydrochloride, and what generic alternatives are available?
Metformin Hydrochloride; Saxagliptin Hydrochloride is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.
The generic ingredient in METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE is metformin hydrochloride; saxagliptin hydrochloride. There are forty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; saxagliptin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metformin Hydrochloride; Saxagliptin Hydrochloride
A generic version of METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE was approved as metformin hydrochloride; saxagliptin hydrochloride by DR REDDYS LABS SA on August 9th, 2023.
Summary for METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
Recent Clinical Trials for METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sabyasachi Sen | Phase 4 |
Shenzhen Sixth People's Hospital | Phase 4 |
Dongguan Kanghua Hospital | Phase 4 |
See all METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE clinical trials
Pharmacology for METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
Drug Class | Biguanide Dipeptidyl Peptidase 4 Inhibitor |
Mechanism of Action | Dipeptidyl Peptidase 4 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
KOMBIGLYZE XR | Extended-release Tablets | metformin hydrochloride; saxagliptin hydrochloride | 5 mg/500 mg 2.5 mg/1000 mg 5 mg/1000 mg | 200678 | 3 | 2013-07-31 |